Leukocyte Count and Vascular Risk in Symptomatic Intracranial Atherosclerosis.
From: Stroke Center and Department of Neurology, UCLA Medical Center, Los Angeles, CA 90095, USA. ovibes@mednet.ucla.edu
Cerebrovascular diseases (Basel, Switzerland)
- Publish Date: 2007
- ISSN: 1015-9770
- Volume: 24
- Issue: 2-3
- Pages: 283-8
- Medium: Print
- Language: English
- Citation (JAMA): Ovbiagele Bruce, Lynn Michael J, Saver Jeffrey L, et al. Leukocyte Count and Vascular Risk in Symptomatic Intracranial Atherosclerosis.. Cerebrovasc. Dis. 2007;24:283-8
Abstract
BACKGROUND: Few data exist about the prognostic value of serum white blood cell (WBC) count among patients with symptomatic cerebrovascular disease. We investigated the relationship between WBC count and vascular risk in patients with symptomatic intracranial atherosclerotic disease enrolled in the Warfarin-Aspirin Symptomatic Intracranial Disease(WASID) study. METHODS: The relationships between baseline serum WBC count (categorized into quartiles) and both ischemic stroke alone and the combined endpoint of ischemic stroke, myocardial infarction or vascular death were evaluated using the log-rank test and Cox proportional hazards regression. RESULTS: Compared with the quartile with the lowest WBC counts at baseline (< or =5.9 x 10(9)/l), WASID subjects in both upper WBC quartiles (7.3-8.8; > or =8.9 x 10(9)/l) were more likely to be younger (p = 0.022), diabetic (p = 0.013), on statin treatment (p = 0.015), or have higher mean body mass index (p = 0.015) and triglyceride (p = 0.0065) values. The rate of the primary endpoint was greater among WASID subjects in the upper two WBC quartiles compared with the lower two quartiles (28 vs. 16%, hazard ratio = 1.7; 95% CI = 1.2-2.5, p = 0.003). After adjusting for baseline factors found to be significantly related to the time of primary endpoint in multivariate analysis, both upper WBC quartiles (vs. lowest quartile) were independently associated with a greater risk for the primary endpoint (hazard ratio of 1.5; 95% CI = 1.06-2.2, p = 0.024). CONCLUSIONS: An elevated WBC count at study entry was associated with an increased risk of stroke and vascular death in patients with symptomatic intracranial atherosclerotic disease enrolled in the WASID trial.
Mesh Headings (Keywords): Adult, Aged, Anticoagulants, Aspirin, Constriction, Pathologic, Female, Humans, Intracranial Arteriosclerosis, Leukocyte Count, Male, Middle Aged, Myocardial Infarction, Prognosis, Proportional Hazards Models, Risk Assessment, Risk Factors, Stroke, Time Factors, Warfarin
Check for Full Text / PubMed Unique Identifier (PMID): 17646693
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.